{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:06:29Z","timestamp":1792181189247,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.eururo.2008.05.010","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T08:53:21Z","timestamp":1211446401000},"page":"1164-1178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":266,"title":["Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy"],"prefix":"10.1016","volume":"54","author":[{"given":"Kurt G.","family":"Naber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Schito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1A","key":"10.1016\/j.eururo.2008.05.010_bib1","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.eururo.2008.05.010_bib2","series-title":"Detection, prevention and management of UTIs","author":"Kunin","year":"1997"},{"key":"10.1016\/j.eururo.2008.05.010_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-5347(17)36292-4","article-title":"Urinary tract infections in healthy university men","volume":"149","author":"Krieger","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.05.010_bib4","series-title":"Urinary tract infections","first-page":"46","article-title":"Urinary tract infections in young men","author":"Stamm","year":"1997"},{"key":"10.1016\/j.eururo.2008.05.010_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001432-200502000-00009","article-title":"Urinary tract infections in diabetes","volume":"18","author":"Nicolle","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2008.05.010_bib6","first-page":"10","article-title":"Urinary tract infection in pregnancy","volume":"80","author":"MacLean","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2008.05.010_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/313596","article-title":"Recurrent urinary tract infections in postmenopausal women","volume":"30","author":"Raz","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eururo.2008.05.010_bib8","unstructured":"Naber KG, Bishop MC, Bjerklund-Johansen TE, et al. The management of urinary and male genital tract infections. In: European Association of Urology, editor. Guidelines edition 2007. ISBN-13: 978-90-70244-59-0."},{"key":"10.1016\/j.eururo.2008.05.010_bib9","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, ed 7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.eururo.2008.05.010_bib10","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 17th Informational supplement. Wayne, PA: CLSI; 2007."},{"key":"10.1016\/j.eururo.2008.05.010_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJM198208193070802","article-title":"Diagnosis of coliform infection in acutely dysuric women","volume":"307","author":"Stamm","year":"1982","journal-title":"New Engl J Med"},{"issue":"Suppl 20","key":"10.1016\/j.eururo.2008.05.010_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0924-8579(03)00231-0","article-title":"Why fosfomycin trometanol as first line therapy for uncomplicated UTI?","volume":"22","author":"Schito","year":"2003","journal-title":"Int J Antimicr Agents"},{"key":"10.1016\/j.eururo.2008.05.010_bib13","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0924-8579(03)00238-3","article-title":"Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection","volume":"22","author":"Hooton","year":"2003","journal-title":"Int J Antimicr Agents"},{"issue":"Suppl S1","key":"10.1016\/j.eururo.2008.05.010_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/46.suppl_1.15","article-title":"The ECO-SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens \u2013 interim report","volume":"46","author":"Kahlmeter","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eururo.2008.05.010_bib15","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0924-8579(03)00229-2","article-title":"Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO SENS study","volume":"22","author":"Kahlmeter","year":"2003","journal-title":"Int J Antimicr Agents"},{"key":"10.1016\/j.eururo.2008.05.010_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/joc.2005.17.3.251","article-title":"Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines","volume":"17","author":"Fadda","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.eururo.2008.05.010_bib17","first-page":"399","article-title":"Single-dose treatment of cystitis with fosfomycin trometanol (Monuril): analysis of 15 comparative trials on 2,048 patients","volume":"19","author":"Lecomte","year":"1997","journal-title":"Giorn It Ost Gin"},{"key":"10.1016\/j.eururo.2008.05.010_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","article-title":"A comparison between single-dose fosfomycin trometanol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women","volume":"10","author":"Minassian","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eururo.2008.05.010_bib19","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2008.05.010_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/46.suppl_1.35","article-title":"Pivmecillinam in the treatment of urinary tract infections","volume":"46","author":"Nicolle","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eururo.2008.05.010_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","author":"Nicolle","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eururo.2008.05.010_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2004.02106.x","article-title":"Increased treatment failure after 3-days\u2019 courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database","volume":"58","author":"Goettsch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl A","key":"10.1016\/j.eururo.2008.05.010_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/33.suppl_A.121","article-title":"Nitrofurantoin modified release versus trimethoprim or cotrimoxazole in the treatment of uncomplicated urinary tract infection in general practice","volume":"33","author":"Spencer","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eururo.2008.05.010_bib24","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","author":"Gupta","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2008.05.010_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial","volume":"293","author":"Hooton","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2008.05.010_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01739308","article-title":"Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women","volume":"21","author":"Naber","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.eururo.2008.05.010_bib27","unstructured":"Deutsches Institut f\u00fcr Normung e.V.: Medizinische Mikrobiologie \u2013 Empfindlichkeitspr\u00fcfung von mikrobiellen Krankheitserregern gegen Chemotherapeutika \u2013 Teil 4: Bewertungsstufen f\u00fcr die minimalen Hemmkonzentrationen \u2013 MHK-Grenzwerte von antibakteriellen Wirkstoffen. Beiblatt zu DIN 58940-1. August 2005, Beuth, Berlin, DIN 58940-4 Bbl 1:2004. (Medical Microbiology \u2013 Susceptibility testing of microbial pathogens against chemotherapeutics \u2013 part 4: Breakpoints for minimal inhibitory concentrations \u2013 MIC breakpoints of antibacterial substances. Supplement to DIN 58940, edition 1st August 2005. Beuth, Berlin, DIN 58940-4 Bbl 1:2004.)"},{"issue":"Suppl S1","key":"10.1016\/j.eururo.2008.05.010_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/46.suppl_1.49","article-title":"Survey on antibiotic usage in the treatment of urinary tract infections","volume":"46","author":"Naber","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eururo.2008.05.010_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eururo.2008.05.010_bib30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","article-title":"Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with high prevalence of TMP-SMX-resistant uropathogens","volume":"34","author":"Raz","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808006209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808006209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:01:49Z","timestamp":1759582909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808006209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0302283808006209"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.05.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1144843.601929","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2008.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}